Interest Paid
Alnylam Pharmaceuticals Interest Paid decreased by 43.3% to $64.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.9%, from $68.93M to $64.20M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 72.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
Detailed definition
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Peer comparison
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paidHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.16M | $6.16M | $6.16M | $14.12M | $14.94M | $14.87M | $1.30M | $13.91M | $3.22M | $9.55M | $5.44M | $30.95M | $8.16M | $16.15M | $12.33M | $68.93M | $12.57M | $23.89M | $113.32M | $64.20M |
| QoQ Change | — | +0.0% | +0.0% | +129.1% | +5.8% | -0.5% | -91.2% | +967.7% | -76.9% | +196.9% | -43.0% | +468.5% | -73.6% | +98.0% | -23.6% | +459.1% | -81.8% | +90.1% | +374.3% | -43.3% |
| YoY Change | — | — | — | — | +142.4% | +141.3% | -78.9% | -1.5% | -78.5% | -35.8% | +317.7% | +122.4% | +153.6% | +69.1% | +126.5% | +122.8% | +54.1% | +48.0% | +819.0% | -6.9% |
Interest Paid at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's interest paid?
- Alnylam Pharmaceuticals (ALNY) reported interest paid of $64.20M in Q1 2026.
- How has Alnylam Pharmaceuticals's interest paid changed year-over-year?
- Alnylam Pharmaceuticals's interest paid decreased by 6.9% year-over-year, from $68.93M to $64.20M.
- What is the long-term trend for Alnylam Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's interest paid has grown at a 72.6% compound annual growth rate (CAGR), from $24.66M to $218.71M.
- What does interest paid mean?
- The actual cash paid to lenders for interest on debt.